Cubist Systematic Strategies’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-38,651
| Closed | -$135K | – | 1535 |
|
|
2024
Q2 | $135K | Buy |
38,651
+16,922
| +78% | +$58.9K | ﹤0.01% | 1137 |
|
|
2024
Q1 | $61.9K | Buy |
+21,729
| New | +$61.9K | ﹤0.01% | 1885 |
|
|
2023
Q3 | – | Sell |
-20,525
| Closed | -$80.9K | – | 2018 |
|
|
2023
Q2 | $80.9K | Buy |
+20,525
| New | +$80.9K | ﹤0.01% | 1851 |
|
|
2022
Q4 | – | Sell |
-58,978
| Closed | -$238K | – | 3280 |
|
|
2022
Q3 | $238K | Sell |
58,978
-16,041
| -21% | -$64.7K | ﹤0.01% | 2897 |
|
|
2022
Q2 | $335K | Buy |
75,019
+37,616
| +101% | +$168K | ﹤0.01% | 2864 |
|
|
2022
Q1 | $318K | Sell |
37,403
-99,933
| -73% | -$850K | ﹤0.01% | 2785 |
|
|
2021
Q4 | $1.21M | Buy |
137,336
+69,436
| +102% | +$613K | 0.01% | 1770 |
|
|
2021
Q3 | $706K | Buy |
+67,900
| New | +$706K | 0.01% | 1789 |
|